Ignite Creation Date:
2025-12-24 @ 12:20 PM
Ignite Modification Date:
2025-12-26 @ 7:36 AM
Study NCT ID:
NCT01927861
Status:
COMPLETED
Last Update Posted:
2020-08-10
First Post:
2013-08-20
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Investigating the Long-term Efficacy and Safety of Two Doses of NN-220 (Somatropin) in Short Stature Due to Noonan Syndrome
Sponsor:
Novo Nordisk A/S
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-08-19
Start Date Type:
ACTUAL
Primary Completion Date:
2018-07-12
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-07-12
Completion Date Type:
ACTUAL
First Submit Date:
2013-08-20
First Submit QC Date:
None
Study First Post Date:
2013-08-23
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2019-07-04
Results First Submit QC Date:
None
Results First Post Date:
2019-10-14
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2020-07-27
Last Update Post Date:
2020-08-10
Last Update Post Date Type:
ACTUAL